- PROCTO3 REPORT AT Gastroenterology, Hepatobiliary, and Biliary Department - FV HOSPITAL (17/01/2024 )
- GLIGCA REPORT AT SPINE DEPARTMENT B – HCMC ORTHOPEDIC TRAUMA HOSPITAL (17/01/2024 )
- REPORT TAMDEFLO ORTHOPEDIC TRAUMA DEPARTMENT (17/01/2024 )
- CAPSER REPORT FOR MUSCULOSCOPIC AND JOINT DEPARTMENT OF CHO RAY HOSPITAL (17/01/2024 )
- TAMDEFLO MINH DUC HOSPITALOn October 21, 2023, Medbolide Joint Stock Company had a report to introduce the product TAMDEFLO (deflazacort 6mg) at the hall of Minh Duc Hospital, Ben Tre. The report took place with the participation of more than 30 Doc (17/01/2024 )
- Report TAMDEFLO Thong Nhat Hospital (17/01/2024 )
- Report TAMDEFLO MEDIC BINH DUONG (17/01/2024 )
- GLIGCA REPORT AT THE PHARMACY DEPARTMENT - FV HOSPITAL (11/01/2024 )
- CAPSER – ENDOCRINE DEPARTMENT, CHO RAY HOSPITAL (16/10/2023 )
- Report CAPSER, DEGODAS – JOINT DEPARTMENT OF ORTHOPEDIC TRAUMA HOSPITAL (16/10/2023 )
REPORT TAMDEFLO, CAPSER, VOCFOR, DEGODAS CAN THO CENTRAL GERD
November 20, 2023, at the Department of Trauma and Orthopedics, Can Tho Central General Hospital.
CPDP Medbolide Company had a report introducing products TAMDEFLO (deflazacort 6mg), CAPSER (Capsaicin 0.075%), VOCFOR (Lornoxicam 4mg) and DEGODAS (Ibandronate 2.5mg).
Tamdeflo (Deflazacort 6mg) - New generation corticosteroids help limit typical side effects of corticosteroids.
Capser (Capsaicin 0.075%) – New choice in nerve pain relief.
Vocfor (Lornoxicam 4mg) – NSAID-resistant pain reliever, balances COX1/COX2 to limit side effects on the heart and stomach.
Degodas (Ibandronate 2.5mg) – Effective solution in preventing and treating osteoporosis for postmenopausal women.
Medbolide aims to develop new active ingredients with outstanding advantages that are currently imported. Providing the best treatment options for patients, contributing to improving the health of the community.
Readers comments